Determination of a novel targeted drug SKLB-1103 by HPLC

WANG Xiao-yan,ZHONG Lei,FU Xiao-yu,YANG Hui-wen,LI Lin-li

DOI: https://doi.org/10.13375/j.cnki.wcjps.2012.06.032

2012-01-01

Abstract:OBJECTIVE To establish a content determination method of a novel targeted drug SKLB-1103 for treating acute myeloid leukemia and to investigate its stability.METHODS In the method,Waters XTerra C18 column was used.The mobile phase A was acetonitrile and the mobile phase B was water containing 20 mmol·L-1 ammonium acetate(adjusted pH to 9.5 with ammonia).The UV detection wavelength was 288 nm,the column temperature was 35 ℃ and the flow rate was 1.0 mL·min-1.RESULTS SKLB-1103 could be effectively separated with impurities.The calibration curve was linear in the range of 1-100 μg·mL-1(r=0.9999).The average recovery was 98.36%(RSD=1.6%).The reproducibility was 1.1%,and the precisions at different concentrations were 0.22%,0.64% and 0.14%,respectively.SKLB-1103 was stable to both moisture and heat,but unstable to light.CONCLUSION The method is selective,simple and accurate.It is applicable for the analysis of SKLB-1103 in the presence of its degradants.